Correlation Between Enliven Therapeutics and Vericel Corp
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Vericel Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Vericel Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Vericel Corp Ord, you can compare the effects of market volatilities on Enliven Therapeutics and Vericel Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Vericel Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Vericel Corp.
Diversification Opportunities for Enliven Therapeutics and Vericel Corp
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enliven and Vericel is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Vericel Corp Ord in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vericel Corp Ord and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Vericel Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vericel Corp Ord has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Vericel Corp go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Vericel Corp
Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the Vericel Corp. But the stock apears to be less risky and, when comparing its historical volatility, Enliven Therapeutics is 1.06 times less risky than Vericel Corp. The stock trades about -0.19 of its potential returns per unit of risk. The Vericel Corp Ord is currently generating about 0.43 of returns per unit of risk over similar time horizon. If you would invest 4,404 in Vericel Corp Ord on September 1, 2024 and sell it today you would earn a total of 1,410 from holding Vericel Corp Ord or generate 32.02% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Enliven Therapeutics vs. Vericel Corp Ord
Performance |
Timeline |
Enliven Therapeutics |
Vericel Corp Ord |
Enliven Therapeutics and Vericel Corp Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enliven Therapeutics and Vericel Corp
The main advantage of trading using opposite Enliven Therapeutics and Vericel Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Vericel Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vericel Corp will offset losses from the drop in Vericel Corp's long position.Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
Vericel Corp vs. Tff Pharmaceuticals | Vericel Corp vs. Eliem Therapeutics | Vericel Corp vs. Inhibrx | Vericel Corp vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |